Today: 9 June 2026
Booking Holdings (BKNG) stock slides as visa pause and China probe hit travel shares

Booking Holdings (BKNG) stock slides as visa pause and China probe hit travel shares

New York, January 14, 2026, 20:52 EST — The market has closed.

  • Booking Holdings shares dropped 2.4% Wednesday, marking their third straight day of losses.
  • Shares in travel rivals Expedia and Tripadvisor dipped, with Trip.com’s U.S.-listed ADRs plunging 17%.
  • Traders are eyeing the fallout from shifts in U.S. immigration policy and increased regulatory focus on travel platforms.

Booking Holdings Inc shares slipped 2.4% on Wednesday, closing at $5,187.02. This marked their third day of losses, though they still outperformed some rivals in the travel sector. Expedia Group shares dropped 3.1%, Tripadvisor fell 7.1%, and Trip.com Group’s U.S.-listed ADRs plunged 17.1%.

Selling matters now since travel stocks have become a barometer for policy risk tied to cross-border movement, beyond just consumer demand. Investors also worry regulators might crack down on fees and market dominance at online travel platforms.

Booking finds itself caught in the middle of these forces. It sells hotel nights and other travel services internationally, so changes in consumer mood quickly affect its booking trends and advertising budgets.

China’s market regulator has launched an antitrust probe into Trip.com, citing suspected monopolistic behavior but offering no specifics. Authorities warned that firms violating the anti-monopoly law could be hit with fines ranging from 1% to 10% of their previous year’s revenue. Trip.com confirmed it is cooperating fully.

The Trump administration announced it will halt immigrant visa processing for applicants from 75 countries beginning Jan. 21, as the State Department reviews procedures aimed at blocking potential “public charges” from entering the U.S. A spokesperson clarified that visitor visas remain unaffected—key as the U.S. prepares to host the 2026 World Cup. Reuters

New tourism figures deepened concerns. Despite a 6.7% rise in global tourism spending, the U.S. saw a 6% decline in foreign visitors in 2025, industry data shows. WTTC’s interim chief Gloria Guevara pointed to U.S. anti-immigration policies as a factor driving travelers to Europe and Japan.

Wall Street slipped on Wednesday, dragged down by the Nasdaq as investors sought safety amid mixed big-bank earnings and new economic reports. The broader market offered little support.

Policy headlines pose mixed signals for Booking. The U.S. visa pause focuses on immigrant visas, not tourist travel, and with a global customer base, the company can absorb shocks from one country. Still, stricter screening and additional restrictions could drag down travel overall or hit consumer confidence ahead of the spring booking season.

Thursday’s session will hinge on whether travel stocks find footing after Trip.com’s drop and if new details surface about the U.S. visa pause rollout. The next key date is Jan. 21, when the suspension is set to begin.

Stock Market Today

  • U.S. Inflation Poised to Exceed 4% for First Time Since 2023, Pressures Mount on Fed
    June 9, 2026, 10:06 AM EDT. U.S. inflation is set to surpass 4% for the first time since 2023, signaling rising consumer prices and intensifying economic pressures. This uptick, measured by the year-over-year increase in the Consumer Price Index (CPI), highlights renewed challenges for the Federal Reserve (Fed) as it grapples with balancing inflation control against economic growth. The rise in inflation may influence the Fed's monetary policy decisions amid concerns over sustained price increases impacting households and businesses for the remainder of the year.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
Morgan Stanley stock slips before earnings as Wall Street digests big-bank signals
Previous Story

Morgan Stanley stock slips before earnings as Wall Street digests big-bank signals

NASA pulls Crew-11 from ISS in first medical evacuation as SpaceX Dragon heads for splashdown
Next Story

NASA pulls Crew-11 from ISS in first medical evacuation as SpaceX Dragon heads for splashdown

Go toTop